NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

ALZI

TSXV:ALZITSXV
9 announcements
Credibility Score63%
ALZAI Health Corp. Enters into MOU with Quanterix Corporation to Advance Early Alzheimer's Disease Identification
RoutineModerate hypeunclear

ALZAI signed a non-binding MOU with Quanterix to explore Alzheimer's diagnostics collaboration.

13 Nov 2026, 11:00 UTC
▼
Alzai Health Corp. Joins Alzheimer's Association Business Consortium to Advance Alzheimer's Research and Innovation
RoutineModerate hypeunclear

ALZAI joins AABC, signalling intent but offering no immediate commercial or financial impact.

5 Nov 2026, 11:00 UTC
▼
Alzai Health Corp. Provides Update Regarding Marketing Services Agreement with Euro Digital Media
Routineunclear

Alzai Health commits US$425,000 to a four-month digital marketing campaign, pending TSXV approval.

2 Nov 2026, 11:00 UTC
▼
ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market
Routineunclear

ALZAI Health Corp. begins trading on the OTCQB, expanding access for U.S. investors.

20 Oct 2026, 11:00 UTC
▼
Alzai Health Corp. Announces Marketing Services Agreement
Routineunclear

Alzai is spending US$425,000 on a year-long digital marketing campaign.

17 Aug 2026, 10:05 UTC
▼
ALZAI and Linus Health Explore AI-Driven Collaborations Aimed at Early Identification of Alzheimer's Disease Risk and Cognitive Impairment
RoutineModerate hypeunclear

ALZAI signed a non-binding MOU with Linus Health; no financials or deals disclosed.

11 Aug 2026, 10:04 UTC
▼
ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology
OverhypedModerate hypeunclear

ALZAI’s licensing deal is all promise, no proof—investors get hype, not hard numbers.

20 Jul 2026, 10:09 UTC
▼
ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data
OverhypedModerate hypeunclear

Technical validation is real, but commercial and financial impact remains entirely unproven.

6 Jul 2026, 10:18 UTC
▼
Alzai Health Corp. Signs Strategic U.S. Commercialization Agreement with Centauri Health Solutions to Advance AI-Driven Alzheimer's Risk Identification
OverhypedModerate hypeunclear

Big promises, little proof—investors face long odds and longer timelines here.

2 Jul 2026, 10:55 UTC
▼